Neville Rodie & Shaw’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,494
| Closed | -$392K | – | 250 |
|
|
2023
Q3 | $392K | Sell |
3,494
-6
| -0.2% | -$762 | 0.04% | 195 |
|
|
2023
Q2 | $509K | Hold |
3,500
| – | – | 0.04% | 179 |
|
|
2023
Q1 | $452K | Hold |
3,500
| – | – | 0.04% | 189 |
|
|
2022
Q4 | $446K | Hold |
3,500
| – | – | 0.04% | 188 |
|
|
2022
Q3 | $366K | Hold |
3,500
| – | – | 0.04% | 196 |
|
|
2022
Q2 | $368K | Hold |
3,500
| – | – | 0.03% | 203 |
|
|
2022
Q1 | $448K | Sell |
3,500
-105
| -3% | -$12.7K | 0.03% | 201 |
|
|
2021
Q4 | $445K | Hold |
3,605
| – | – | 0.03% | 202 |
|
|
2021
Q3 | $512K | Hold |
3,605
| – | – | 0.04% | 181 |
|
|
2021
Q2 | $563K | Hold |
3,605
| – | – | 0.04% | 175 |
|
|
2021
Q1 | $560K | Hold |
3,605
| – | – | 0.05% | 170 |
|
|
2020
Q4 | $539K | Sell |
3,605
-2,348
| -39% | -$332K | 0.05% | 159 |
|
|
2020
Q3 | $787K | Sell |
5,953
-149
| -2% | -$19.5K | 0.07% | 127 |
|
|
2020
Q2 | $707K | Hold |
6,102
| – | – | 0.07% | 133 |
|
|
2020
Q1 | $599K | Hold |
6,102
| – | – | 0.07% | 133 |
|
|
2019
Q4 | $886K | Sell |
6,102
-72
| -1% | -$9.94K | 0.09% | 133 |
|
|
2019
Q3 | $822K | Sell |
6,174
-354
| -5% | -$45.7K | 0.09% | 132 |
|
|
2019
Q2 | $747K | Hold |
6,528
| – | – | 0.08% | 142 |
|
|
2019
Q1 | $810K | Hold |
6,528
| – | – | 0.09% | 133 |
|
|
2018
Q4 | $658K | Hold |
6,528
| – | – | 0.08% | 141 |
|
|
2018
Q3 | $833K | Sell |
6,528
-42
| -0.6% | -$4.99K | 0.08% | 138 |
|
|
2018
Q2 | $711K | Hold |
6,570
| – | – | 0.08% | 148 |
|
|
2018
Q1 | $695K | Hold |
6,570
| – | – | 0.08% | 145 |
|
|
2017
Q4 | $770K | Hold |
6,570
| – | – | 0.08% | 145 |
|
|
2017
Q3 | $747K | Hold |
6,570
| – | – | 0.08% | 147 |
|
|
2017
Q2 | $819K | Sell |
6,570
-660
| -9% | -$78.2K | 0.09% | 134 |
|
|
2017
Q1 | $857K | Hold |
7,230
| – | – | 0.1% | 138 |
|
|
2016
Q4 | $725K | Hold |
7,230
| – | – | 0.09% | 142 |
|
|
2016
Q3 | $913K | Sell |
7,230
-540
| -7% | -$66.7K | 0.11% | 137 |
|
|
2016
Q2 | $908K | Sell |
7,770
-567
| -7% | -$64.2K | 0.11% | 138 |
|
|
2016
Q1 | $863K | Hold |
8,337
| – | – | 0.1% | 134 |
|
|
2015
Q4 | $831K | Buy |
8,337
+16
| +0.2% | +$1.56K | 0.1% | 138 |
|
|
2015
Q3 | $759K | Sell |
8,321
-103
| -1% | -$10.3K | 0.09% | 142 |
|
|
2015
Q2 | $893K | Hold |
8,424
| – | – | 0.1% | 144 |
|
|
2015
Q1 | $961K | Hold |
8,424
| – | – | 0.1% | 145 |
|
|
2014
Q4 | $928K | Sell |
8,424
-103
| -1% | -$10.9K | 0.09% | 147 |
|
|
2014
Q3 | $833K | Buy |
8,527
+2,027
| +31% | +$199K | 0.08% | 148 |
|
|
2014
Q2 | $655K | Sell |
6,500
-721
| -10% | -$70.3K | 0.07% | 156 |
|
|
2014
Q1 | $663K | Sell |
7,221
-942
| -12% | -$86.8K | 0.07% | 145 |
|
|
2013
Q4 | $738K | Sell |
8,163
-51
| -0.6% | -$4.41K | 0.08% | 134 |
|
|
2013
Q3 | $655K | Sell |
8,214
-155
| -2% | -$12.2K | 0.08% | 140 |
|
|
2013
Q2 | $609K | Buy |
+8,369
| New | +$626K | 0.07% | 141 |
|
Other funds holding ZBH
Neville Rodie & Shaw's ZBH Position: Q4 2023 in Review
Neville Rodie & Shaw sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 3,494 shares — an estimated $392K sold.
Neville Rodie & Shaw first reported a position in ZBH in Q2 2013 and held it in 42 quarters. The position peaked at $961K in Q1 2015. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.
- Neville Rodie & Shaw reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
- Neville Rodie & Shaw sold 3,494 Zimmer Biomet shares in Q4 2023, an estimated $392K.
- Neville Rodie & Shaw first reported a position in Zimmer Biomet in Q2 2013 and held it in 42 quarters.
- Neville Rodie & Shaw's Zimmer Biomet position peaked at $961K in Q1 2015.
- 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.
Based on Neville Rodie & Shaw's 13F filing for Q4 2023, filed 2 Jan 2024.